Patents by Inventor Sonja Sproll

Sonja Sproll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate
    Patent number: 8551987
    Abstract: The invention relates to the novel salts AB of the base A with a physiologically acceptable acid B which is selected from the group consisting of hydrochloric acid, hydrobromic acid, sulfuric acid, fumaric acid and salicylic acid and the polymorphic compounds, the corresponding solvates and hydrates thereof.
    Type: Grant
    Filed: September 25, 2008
    Date of Patent: October 8, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Kathrin Pachur, Uwe Joerg Ries, Ulrike Werthmann, Sonja Sproll
  • NOVEL COMPOUNDS
    Publication number: 20120058994
    Abstract: The invention relates to the novel salts AB of the base A with a physiologically acceptable acid B which is selected from the group consisting of hydrochloric acid, hydrobromic acid, sulfuric acid, fumaric acid and silcylic acid and the polymorphic compounds, the corresponding solvates and hydrates thereof.
    Type: Application
    Filed: September 25, 2008
    Publication date: March 8, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Kathrin Pachur, Uwe Joerg Ries, Ulrike Werthmann, Sonja Sproll
  • Crystalline compounds
    Patent number: 7638625
    Abstract: The present invention relates to the new crystalline compounds A of general formula I wherein A1, A2, A3, X, Y1, Y2 and Y3 are defined as in claim 1, and which are present in the form of their physiologically acceptable salts with acids, the acids being selected from the group B comprising hydrochloric acid, hydrobromic acid, sulphuric acid, phosphoric acid, benzenesulphonic acid, p-toluenesulphonic acid, maleic acid, succinic acid, fumaric acid, D-(?)-tartaric acid, L-(+)-tartaric acid, naphthalene-2-sulphonic acid and naphthalene-1,5-disulphonic acid, and the polymorphs, the corresponding solvates and hydrates thereof.
    Type: Grant
    Filed: April 12, 2007
    Date of Patent: December 29, 2009
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Uwe Ries, Guenther Huchler, Sonja Sproll, Ulrike Werthmann, Andreas Zopf
  • Crystalline Compounds
    Publication number: 20080086003
    Abstract: The present invention relates to the new crystalline compounds A of general formula I wherein A1, A2, A3, X, Y1, Y2 and Y3 are defined as in claim 1, and which are present in the form of their physiologically acceptable salts with acids, the acids being selected from the group B comprising hydrochloric acid, hydrobromic acid, sulphuric acid, phosphoric acid, benzenesulphonic acid, p-toluenesulphonic acid, maleic acid, succinic acid, fumaric acid, D-(?)-tartaric acid, L-(+)-tartaric acid, naphthalene-2-sulphonic acid and naphthalene-1,5-disulphonic acid, and the polymorphs, the corresponding solvates and hydrates thereof.
    Type: Application
    Filed: April 12, 2007
    Publication date: April 10, 2008
    Inventors: Uwe RIES, Guenther HUCHLER, Sonja SPROLL, Ulrike WERTHMANN, Andreas ZOPF